IL6 and atrial fibrillation: Our research in humans demonstrated that genetic variants in IL6R was associated with a recurrence of AF after ablation, and these results support the idea that inflammation, especially the IL6–IL6R pathway, has important effects on the risk of AF recurrence after ablation.